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 Protein tyrosine O-sulfation (PTS) is a common post-translational modification that has 
been implicated in a variety of biological processes and human illnesses. Despite continued 
progress in the field of sulfoproteomics, the extent and function of sulfated tyrosine 
(sulfotyrosine) residues is a topic of ongoing research. Previous work in the Guo Lab has 
identified Src Homology-2 (SH2) mutants that have a high affinity for sulfotyrosine along with 
retained high affinity for their natural ligand, phosphorylated tyrosine (phosphotyrosine). In this 
thesis, I attempted to generate SH2 mutants that have high affinity and specificity for 
sulfotyrosine over phosphotyrosine. While I successfully generated SH2 libraries and conducted 
a series of selections, I was not able to identify any SH2 mutants with desirable properties. 
Although the challenging research was not achieved in this thesis, there is still much to be 
learned from a careful examination of the methods employed here and of the literature 
surrounding the creation of small molecule binders through library design and phage display 
technology. 
Chapter 1 provides a short introduction to the current state of research into PTS, and into 
the applications of SH2 mutants. In Chapter 2, Kunkel mutagenesis is introduced as an approach 
to generating a library of SH2 mutants that incorporates soft randomization. Chapter 3 is an 
attempt at modifying phage display techniques to screen a large, previously generated SH2 
library. Finally, a Boolean OR-Type library is attempted in Chapter 4 as another approach for 
generating a smaller, yet still diverse, SH2 library. Though none of these methods were 
successful individually in reaching the ultimate goal, future work may incorporate the lessons 
learned from each of these chapters to successfully generate a small protein domain with 
specificity for sulfotyrosine over phosphotyrosine. 
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CHAPTER 1: INTRODUCTION 
Protein tyrosine O-sulfation (PTS) is a common tyrosine post-translational modification 
(PTM)1 that was first described in a 1954 study2. As more research has been conducted into the 
nature of this modification, it is now known that the modification is installed onto tyrosine 
residues in the trans-Golgi through the action of the tyrosyl-protein sulfotransferase enzyme 
(TPST)3,4. The reaction is described in Figure 1. 
 
Figure 1.  TPST-catalyzed reaction. TPST accepts a sulfate from the universal sulfate donor 3’ 
phospoadenosine-5’-phosphosulfate (PAPS) and transfers sulfate to a tyrosine residue. Image 
was adapted from “Protein sulfation analysis-a primer” 4. 
While sulfated tyrosine (sulfotyrosine) has been the subject of a variety of studies1–3,5–7 
and literature reviews4,8,910, the extent of its cellular functions is a topic of ongoing research. 
Early research into the PTM identified it in various rat tissues, including bladder, testis, gut, 
lung, and adrenal glands1. Sulfotyrosine-containing proteins (sulfoproteins) have many functions, 
including regulation of immune responses11, cell signaling12, and blood clotting13. Reduction in 
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PTS of C-C chemokine receptor type 5 (CCR5) drastically reduced the chemokine receptor’s 
affinity for its natural ligands14. Human cellular receptors for human immunodeficiency virus 
(HIV)14, malaria15, and enterovirus 7116 all contain at least one site of PTS that may facilitate 
host infection. Aberrant PTS may also contribute to the development of autoimmune diseases10. 
Due to its many known functions, and likely many more unknown functions, it is important to 
better understand the extent of this PTM in the human proteome.  
Ongoing research into PTS has, in part, been hindered by a lack of methods and tools to 
effectively analyze this PTM. Mass spectrometry17 and TPST enzymatic assays18 have been used 
to study PTS, but both of these methods have limited application for determining where the 
modification occurs in vivo. Mass spectrometry analysis is challenging with complex biological 
samples because sulfotyrosine is in low abundance and unstable under common condition used 
in mass spectrometry. TPST enzymatic assays may sulfate tyrosine residues that are not naturally 
sulfated in vivo. Such methods have allowed for some advancements in knowledge of PTS, but 
more work must be done to continue elucidating sulfotyrosine’s biological functions. 
Research into a similar but more stable PTM, tyrosine O-phosphorylation, has made 
considerable progress. Enrichment methods for phosphorylated tyrosine (phosphotyrosine)-
containing proteins (phosphoproteins) have been well established, in part because the protein 
domain, Src Homology 2 (SH2), has been engineered to bind with high affinity to 
phosphotyrosine. One such high-affinity binder, called the SH2 Triple Mutant (SH2-tm) in this 
thesis due to its three key mutations (T40V, C45A, and K63L), is sometimes also referred to as 
an SH2 “superbinder” to phosphotyrosine19. Its usefulness has been demonstrated in a 
phosphoproteomic study that used an SH2 superbinder and affinity-purification mass 
spectrometry method to identify over 10,000 phosphotyrosine sites, 36% of which were novel20. 
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More recently, the SH2 superbinder has been applied for the investigation as a new cancer 
therapeutic that targets phosphotyrosine signaling pathways21. These advancements exhibit how 
the correct biomolecular tools have the potential to revolutionize our understanding of a PTM 
and advance the study of therapeutics. 
Previously, a member of the Guo Lab used SH2-tm as a starting scaffold and further 
engineered it using phage display to create SH2 mutants with enhanced affinity for 
sulfotyrosine22. This was an important step for PTS research. However, these SH2 mutants still 
retained affinity for phosphotyrosine, and an additional phosphatase treatment step would be 
required to use these SH2 mutants to analyze PTS in complex biological samples.  
My research was therefore intended to engineer SH2 mutants with improved specificity 
for sulfotyrosine over phosphotyrosine. Such SH2 mutants would facilitate further application in 
the analysis of this PTM and could potentially allow for the development of diagnostic and 
therapeutic agents. SH2 was originally chosen because of its demonstrated evolvability, its small 
size compared to existing anti-sulfotyrosine antibodies, and the similarities between 
sulfotyrosine and phosphotyrosine22. The similarities between sulfotyrosine and phosphotyrosine 
were also the main challenge facing my research. Both PTMs have a very similar molecular 
weight, making it challenging to distinguish them using mass spectrometry23. They do have some 
distinctions, including a difference in their electrostatic charge, stability, reversibility, and 
cellular location4.   
None of the methods described in this thesis were able to successfully distinguish the two 
modifications. However, there are still many lessons to be learned from an analysis and 
reflection on the experimental process and possible future directions. 
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CHAPTER 2: SOFT RANDOMIZATION LIBRARY 
2.1 INTRODUCTION 
One of the main challenges of directed evolution is determining which residues will be 
fruitful to randomize. Every additional randomization increases a library’s diversity. If residues 
are chosen correctly, this can increase the possibility of finding SH2 mutants with specificity for 
sulfotyrosine. However, the library screening process is limited by transformation efficiency. As 
library size increases, it becomes less likely that the entire library can be transformed into E. coli 
and screened. 
There are many techniques that can help reduce library size while maintaining a diverse 
set of mutations24,25. Choosing the proper degenerate codons is one common way to reduce 
library size. Degenerate codons allow for numerous possible amino acids at a specific position. 
For example, an NNN codon can code for A, T, G, or C at every nucleotide position within the 
codon. In random mutagenesis, it is more common to use an NNK codon, where K codes for G 
or C in the third position. This reduces the possible DNA sequences within each codon while still 
coding for all 20 amino acids. 
Soft randomizations can also be used to ensure that there are only a few mutated residues 
per SH2 mutant24. To accomplish this, primers are constructed so that the wild-type nucleotide is 
retained approximately 70% of the time, instead of containing an equal probability of each 
nucleotide that is typical of hard randomizations. Soft randomization decreases the likelihood 
that individual SH2 domains in the library contain so many mutated residues that the protein is 
rendered non-functional.  
Soft randomization was especially important for my library, which contains 15 mutation 
sites in proximity of the SH2 binding pocket (Figure 2). Though the theoretical sequence 
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diversity of the library was 6415 possible combinations, the actual diversity of the library was 
lowered because of the bias toward the wild-type sequence at each mutated residue. 
 
Figure 2. Selected mutation sites for soft randomization library. The sites were chosen based 
on their proximity to phosphotyrosine in the binding pocket of SH2 and previous literature, 
which used Crystallography and NMR system (CNS) to determine the optimal residues to 
randomize19. 
 
Another challenge in this library design was incorporating all fifteen desired mutations 
into plasmid DNA without reproducing high amounts of template DNA. Kunkel mutagenesis has 
been used in the past to overcome this constraint during the engineering of phosphotyrosine SH2 
superbinders26. This method was first described in 1985 by Thomas A. Kunkel as a way to 
preferentially degrade template DNA during site-directed mutagenesis experiments27,28. 
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The production of template DNA for Kunkel mutagenesis relies on first transforming 
template DNA into CJ237 E. coli, or a similar dut-/ung- strain that can be infected with M13 
phage. The dut gene normally codes for dUTPase, which degrades excess dUTP in the cell. 
Without this gene, excess dUTP is incorporated when the template plasmid DNA is replicated, 
producing dUssDNA that can be packaged into M13 phage. The ung gene normally codes for 
uracil-N-glycosylase, which degrades uracil in the host genome. Without this gene, template 
dUssDNA does not get degraded in CJ237 cells. Once the dUssDNA is purified from CJ237 
cells, steps are taken to produce heteroduplex, covalently closed circular dsDNA (CCC-
dsDNA).  In this heteroduplex, one strand contains only A, T, C, and G nucleotides with the 
desired mutations, and one strand contains U in place of T at some positions. Upon 
transformation into dut+/ung+ E. coli, the strand containing uracilated DNA should be degraded, 
and only strands containing the desired mutations should be observed. When applied to the 
engineering of phosphotyrosine superbinders, the method successfully produced a mutation 
frequency of approximately 80%26. 
 
2.2 RESULTS AND DISCUSSION 
Two previously described methods were followed to construct a soft randomization 
library for the engineering of sulfotyrosine superbinders26,29. Both were unsuccessful at creating 
a sufficient amount of CCC-dsDNA with the desired mutations incorporated.  
Other attempts to optimize the Kunkel mutagenesis methods were also unsuccessful. 
Figure 3 shows the results of one experiment which attempted four variations of the Kunkel 
mutagenesis protocol. The first modification was a change in the annealing temperature listed in 
the protocol. Instead of only annealing at 50oC, the temperature was progressively lowered from 
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65 oC to 60 oC to 50 oC for five minutes each to ensure that the optimal annealing temperature for 
each primer in solution could be achieved. Another modification was increasing the 
concentration of primers added to the Kunkel mutagenesis reaction mix. This was attempted to 
determine if a lack of sufficient amount of primer was the limiting factor. The third modification 
was increasing the incubation time of the Kunkel mutagenesis reaction to ensure that T7 
polymerase had enough time to elongate the primers in the reaction mix. Finally, one reaction 
was attempted using all of the previously listed modifications in one reaction. 
 
Figure 3. DNA products in variations on Kunkel mutagenesis protocol. Lane 1 contained the 
product of a modified protocol that varied annealing temperatures. Lane 2 contained the product 
of an attempt that used a higher concentration of primers than that listed in the original protocols. 
Lane 3 contained Kunkel mutagenesis product from a protocol involving a longer incubation 
time. Lane 4 incorporated all three of the previously mentioned modifications in one tube. Lane 
5 was a control that used the same conditions as a previous attempt. Lane 6 contained isolated 
dUssDNA template accompanied by a band with lower electrophoretic mobility. Lane 7 
contained a sample from an earlier Kunkel mutagenesis experiment that retained excessive 
amounts of dUssDNA. Lane L contained a 1kb ladder. Products were analyzed in a 1% agarose 
gel. 
 
Overall, varying the annealing temperature seemed to be the most effective method to 
generate CCC-dsDNA without other nonspecific products. All of the attempts contained a thin 
band of intermediate electrophoretic mobility that corresponded to a band observed in the 
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dUssDNA product. This may be remnants of the dUssDNA, as a band of this electrophoretic 
mobility has been observed in published Kunkel mutagenesis experiments29. It may also be 
indication of an unknown contaminant in the dUssDNA, but this possibility was not investigated 
further. All attempts also contained strand-displaced DNA and nicked dsDNA. Strand-displaced 
DNA is the result of excessive T7 polymerase activity that causes primers to extend too far26. 
Nicked dsDNA forms when segments of the DNA are not ligated together. This may result from 
insufficient T4 ligase activity or improper phosphorylation of primers26.  
Based on gel images from published protocols26,29, bands corresponding to the CCC-
dsDNA from Lane 1 of Figure 3 were chosen for extraction and transformation into TOP10F’ E. 
coli. When the product of one Kunkel mutagenesis experiment that varied the annealing 
temperature was transformed into TOP10F’ E. coli and the plasmids generated were sent for 
sequencing, only the template sequence with TAA codons at each mutated residue was obtained 
(Figure 4). It was then determined that continued attempts may not be fruitful, and this specific 
project was abandoned in favor of exploring other library design strategies.  
 
 
Figure 4. Sequencing results from Kunkel mutagenesis experiment. (A) Sequence alignment 
between the template sequence (top strand) and the Eurofins MWG Operon chromatogram 
(bottom strand).  The TAA stop codons on the template strand are highlighted in red and blue. 
The template sequence had complete homology with the sequenced portion of the plasmid 




If CCC-dsDNA was transformed into TOP10F’ as expected, then the template should 
have been degraded during the process of replication. It is possible, though unlikely, that the 
primers with stop codons preferentially bound to the template and were thus incorporated into 
the final product. A more likely scenario is that trying to incorporate three primers instead of a 
smaller number of primers reduced the efficacy of Kunkel mutagenesis. Efficacy may have been 
even further reduced because the primers were in close proximity to each other, though the 
recommended distance between primers was at least 30 nucleotides29. If, during experiments, 
only one primer was incorporated in a given plasmid, rather than two or three, the majority of 
products would still have been stop codons. In the future, it may be fruitful to try using only one 
or two primers instead of three. This would require a careful consideration of which mutations to 
incorporate because not all fifteen mutations could be incorporated in this case. One other 
possibility is that the dUssDNA did not get degraded, and instead the strand with degenerate 
codons was preferentially degraded. This scenario was suspected when nonmutated DNA was 
observed in published Kunkel mutagenesis experiments29. Finally, it is possible that the extracted 
band used in my Kunkel mutagenesis experiments actually contained nicked dsDNA, rather than 
CCC-dsDNA. This would help explain the poor outcomes of this experimental technique. If this 
method is attempted again, care should be taken to ensure that primers are properly 




Kunkel mutagenesis is one technique to incorporate randomizations into a protein library. 
In the past, it has been successfully used to produce and screen libraries that resulted in mutant 
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proteins with a desired function26,29. However, my attempts to re-create this method were 
unsuccessful. There are a variety of reasons why my attempts at Kunkel mutagenesis may have 
been ineffective, ranging from primer design to enzyme activity. In subsequent attempts, 
improvements should be made based on lessons learned from the Kunkel mutagenesis 























CHAPTER 3: LIBRARY 2.1 SELECTION SCHEME 
 
3.1 INTRODUCTION 
At its heart, phage display technology works by presenting a peptide or protein of interest 
on the surface of a bacteriophage which contains the genetic material (phagemid) for the said 
peptide or protein of interest. This allows for experiments that can connect novel protein 
structures and functions to the phagemid of corresponding bacteriophage. Many types of 
bacteriophage can be used in a phage display experiment, including T4, lambda, and M1336. The 
phage display experiments in this chapter and in Chapter 4 utilized M13, a filamentous, non-lytic 
phage that contains circular ssDNA36. These phage bind to E. coli via the F pilus, which is why 
using E. coli strains possessing the F’ episome is important for phage display experiments36.  
In M13 phage, a peptide or protein sequence can be displayed via fusion with the pIII 
protein37. Much research into phage display involves the evolution of antibodies fused to the pIII 
protein6,24,36,38, but this method can also be adapted for other small peptide or protein sequences, 
including the SH2 domain26,35. For the work described here, an entire library of SH2 mutants was 
displayed on the surface of M13 phage. The phages were then subjected to selection based on the 
ability of displayed SH2 mutants to bind to a desired ligand. The ligand in each round of 
selection was one of two biotinylated peptides containing sulfotyrosine (sulfopeptides), and 
different rounds contained different downstream peptide motifs (Figure 5) in order to select for 
SH2 mutants that were specific for sulfotyrosine itself and not its downstream amino acid motif. 
One sequence, sYEEIA, was used because it is the preferred downstream sequence for Src-
SH239. The second sequence, sYEGGA, still contains one adjacent acidic residue, which is 
common for sites of PTS4, but is otherwise only contains glycine and alanine. Each peptide also 
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contained 6-aminohexanoic acid, which was used as a spacer sequence to reduce steric 
hinderance and facilitate unobstructed SH2 binding. 
 
Figure 5. Biotinylated peptides used in phage display experiments. (A) sYEEIA peptide 
sequence. (B) sYEGGA peptide sequence. “aha” is 6-aminohexanoic acid. 
 
Phage display experiments involve iterative cycles of a few key steps. First, transformed 
TOP10F’ E. coli containing a phagemid with the gene of interest are infected with phage, and the 
protein of interest is then incorporated as a pIII coat protein fusion on the surface of propagated 
phage36. Once phage have been propagated, they are isolated from the E. coli and are exposed to 
a bound peptide. Depending on whether selection is positive or negative, a wash step may be 
used to isolate phages that are bound to the peptide35. In either case, phages are subjected to a 
trypsin digestion in the elution step to make any phage containing fused pIII proteins infective36. 
Thus, the cycle continues when fresh TOP10F’ E. coli are infected with the phage. 
In order for phage display to be effective at selecting for the binding capability of 
interest, it must be strategic. Some considerations that can be made to modify the selection 
stringency include the phage type, the peptide type, and the elution type.  
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Each M13 phage contains 3-5 pIII coat proteins that can display a peptide of interest36. 
Different types of M13 phage exhibit either monovalent or oligovalent display, which refers to 
the approximate number of peptides displayed on any one M13 phage. M13KO7 phages exhibit 
monovalent display, in which each phage that displays a peptide of interest has only one on its 
surface. This type of display is widely used because these phages can be easily reproduced in the 
lab. A downside of monovalent display is that, because M13KO7 and similar monovalent display 
phages carry the gene for a wild-type pIII protein, approximately 90% of the phage produced 
using this method do not contain any peptide-fused pIII coat proteins on their surface40. This is 
why monovalent display can be employed in later rounds of selection to increase stringency. 
Oligovalent display, in which the majority of pIII coat proteins are fused to a peptide of 
interest, is accomplished using modified M13 systems which lack a functional pIII gene. This 
drastically increases the number of peptide-fused pIII coat proteins displayed on their surface37. 
This also makes oligovalent display expensive because these phages cannot easily be replicated 
in the lab. The oligovalent display system used in this work was hyperphage37.  
The biggest way to modulate selection stringency in the case of evolving SH2 domains is 
to decide between positive and negative selection schemes. A positive selection scheme screens 
for SH2 mutants with sulfotyrosine binding capabilities by attaching a sulfopeptide to the bottom 
of a neutravidin well. On the other hand, a negative selection scheme selects against SH2 
mutants with phosphotyrosine binding capabilities by attaching a phosphotyrosine-containing 
peptide (phosphopeptide) to the bottom of a neutravidin well and extracting the unbound phage. 
Previous work in the Guo Lab has found that negative selections tend to be too stringent and thus 
only enrich nonspecific phage. 
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Another technique called a competitive selection can also be employed as something in 
between a positive and negative selection41. With this strategy, a sulfopeptide is bound to the 
bottom of a neutravidin well, and phenylphosphate is present in the phage solution. By adjusting 
the concentration of phenylphosphate in the solution, there can be a simultaneous selection for 
the sulfopeptide and against the phosphopeptide, with varying levels of stringency.  
Finally, the elution step normally involves a trypsin digestion to release any phages that 
are bound to a peptide and to ensure that only phages displaying an SH2 domain can infect new 
TOP10F’ E. coli36. Previous work in the Guo Lab found that an elution using phenylsulfate, 
followed by a trypsin digestion in a separate tube, was effective at identifying sulfotyrosine 
binders. This method can reduce the number of nonspecific SH2 domains that are enriched 
because they are likely to remain bound to the neutravidin well, while SH2 that specifically bind 
to phenylsulfate with a high affinity will be released. It also further ensures that the selection of 
SH2 domains that bind to sulfotyrosine in a non-contextual fashion that does not rely on 
surrounding residues.  
 
3.2 RESULTS AND DISCUSSION 
 I designed two selection schemes to screen a large library, Library 2.1, that had already 
been created (Figure 6). Library 2.1 contained hard randomizations of the same 15 residues as 




       
Figure 6. Selection scheme design. The only difference between the two selection strategies 
was the addition of a competitive selection in Enrichment 2 of Scheme 2. 
 
Hyperphage was used during the first two rounds of selection, and stringency was 
increased in the third and fourth round through the use of M13KO7. Some rounds utilized a 
competitive selection with either a 1:2 molar ratio of phenylphosphate to bound sulfopeptide 
(75nM phenylphosphate) or a 3:4 molar ratio of phenylphosphate to bound sulfopeptide 
(112.5nM phenylphosphate). Stringency was also increased through the rotation of sulfopeptides 
in different rounds of selection, and through the introduction of a phenylsulfate elution in later 
rounds of selection. 
Neither selection strategy was successful at eliminating the SH2 bias towards 
phosphotyrosine. This may be due to the limitations imposed by the large library size and hard 
randomizations, which lowered the probability of screening the entire library and raised the 
probability of screening mutants with a disrupted tertiary structure.  
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Enrichment ratios for each round of selection are shown in Figure 7. As is typical of 
enrichments using hyperphage, the second round of panning showed a large enrichment above 
the background37. However, the next rounds of panning were not as promising, showing little 
enrichment in round 3, and no enrichment by round 4. This suggested that no SH2 mutants with 
a higher affinity for sulfotyrosine over phosphotyrosine were obtained, which was later 
confirmed by phage enzyme-linked immunosorbent assays (ELISAs). 
 
Figure 7. Library 2.1 enrichment ratios.  Enrichment ratio was the number of infected cell 
colonies growing on the experimental plate divided by the number of infected cell colonies 
growing on the blank plate. 
 
Two phage ELISAs were conducted using phage from the last two rounds of panning 
(Figures 8 and 10). This was done to better characterize the affinities of the SH2 mutants for a 
biotinylated sulfopeptide (sYEEIA) and for a biotinylated phosphopeptide with the same 





















Library 2.1 Enrichment Ratios
Scheme 1 Scheme 2
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Figure 8. Enrichment 3 phage ELISA. Absorbance was determined using an H4 Synergy plate 
reader. 
 
Scheme 2 showed lower affinity for both the sulfopeptide and the phosphopeptide after 
Enrichment 3 when compared to Scheme 1 (Figure 8). This is likely because of the competitive 
selection that was employed in Enrichment 2 of Scheme 2, but not in Scheme 1. Both schemes 
showed a considerably lower affinity for both peptides when compared to a phage ELISA of 




























Figure 9. Phage ELISA of SH2-tm. As discussed in Chapter 1, SH2-tm is known to have a high 
affinity for the phosphopeptide19 and, to a lesser degree, the sulfopeptide22. 
 
 





















































Enrichment 4 Phage ELISA
sYEEI pYEEI
 24 
After Enrichment 4, phage from both schemes showed very low affinity for either peptide 
(Figure 10). Some hits may have shown slightly higher affinity for the sulfopeptide over the 
phosphopeptide that was not statistically significant. However, this interaction was likely 
nonspecific (binding to some other area of each peptide or the neutravidin well) because the 
absorbance was so low.   
It is difficult to know how much of a library gets screened in one selection, especially 
with large libraries. Screening another portion of Library 2.1 using the same selection strategies 
listed in Figure 6 could yield a beneficial SH2 mutant from a different portion of the library. 
However, it is also possible that combining the rotation of sulfopeptides, competitive selection, 
and the switch to monovalent display increased the stringency of both selection schemes too 
quickly. Further modification of selection strategies combined with modification of the library 
itself could be the most promising strategy for identifying a hit with high specificity and affinity 
for sulfotyrosine over phosphotyrosine.  
There are a few other practical modifications that could be added to future selections. 
One modification is the rotation of blocking agents during each round of panning41. This would 
select against phage that are nonspecifically bound to one specific blocking agent. Another 
option is to include deselection steps against biotin, as this is another epitope to which 
nonspecific SH2 mutants may bind36. Finally, increasing or decreasing the number of washes 
used in each selection can modify the selection stringency, and this has been done on selection 
strategies in the Guo lab in the past. 
Even with continued modification of selection strategies, however, the main challenge for 
identifying SH2 domains with improved selectivity for sulfotyrosine seems to be that 
phosphotyrosine is the SH2 domain’s natural ligand. As the field of structural biology and 
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computational methods expand, it may be interesting to explore other protein scaffolds that could 
be adapted for binding to sulfotyrosine. It is entirely possible that there is a more optimal starting 
scaffold somewhere in nature. Finally, while de novo protein design is not yet capable of 
generating small molecule binders, this may be a possibility in the near future as new 
computational methods continue to be developed42.  
 
3.3 CONCLUSION 
 In this chapter, I attempted two selection strategies for Library 2.1. Neither strategy was 
successful at generating SH2 mutants with higher specificity for sulfotyrosine. Nevertheless, 
there are many other selection strategies described in this chapter that have yet to be explored. 
Yet again, computational methods show increasing promise for identifying sulfotyrosine 
superbinders, and should also be explored in the future. In the meantime, a modified selection 
strategy used in combination with new strategies for library design discussed in other chapters 





CHAPTER 4: BOOLEAN OR-TYPE LIBRARY 
4.1 INTRODUCTION 
Substantial research has been done into directed evolution strategies, which rely on 
various techniques to create proteins with desired function that is not yet observed or easy-to-
isolate from natural sources24,25,30. Many considerations must be made to maximize the 
possibility of reaching the desired protein effect, such as what protein to start with, how big to 
make the library, which residues to mutate, and what selection strategy to use.  
 In general, it is beneficial to consider a starting protein’s evolvability when attempting 
directed evolution. In the case of engineering a protein with enhanced affinity for sulfotyrosine, 
the starting scaffold was chosen to be SH2 because the evolvability of this protein scaffold has 
been demonstrated in previous work that enhanced the protein’s affinity for phosphotyrosine26 
and later sulfotyrosine22. 
Library size is also an important consideration for directed evolution. A large library size 
can allow for the sampling of a larger number of residues within a protein, but this method is 
constrained due to E. coli transformation efficiency limiting the potential library diversity. Such 
a library may be beneficial in the early stages of identifying mutants with a desired effect, such 
as increased selectivity or affinity for sulfotyrosine. However, once a mutant with the desired 
effect has been characterized, it may be more fruitful to explore strategic libraries using the 
beneficial mutant as a template. 
This is exactly what occurred shortly after the identification of SH2 mutant 3.1 was 
identified from an SH2 library which randomized several residues within the phosphotyrosine-
binding pocket. The SH2 mutant 3.1 contained three key mutations in binding pocket residues: 
S37H, E38P, and T39F. These residues likely contributed to the SH2 domain’s enhanced 
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selectivity for sulfotyrosine over phosphotyrosine. However, this came at the expense of affinity 
for both sulfotyrosine and phosphotyrosine as compared to previously engineered SH2 domains. 
In an attempt to modulate the protein’s affinity, it was decided that a smaller library with 
mutations in specific residues would be most prudent. One method to create a smaller library that 
still screens a wide array of potentially beneficial mutants is to use a Boolean OR-type library31. 
This method utilizes asymmetric PCR to create mutagenic megaprimers, each containing one 
mutation. These mutagenic megaprimers can then be combined strategically to produce gene 
inserts, which can be incorporated into a plasmid using Gibson Assembly to produce a complete 
library (Figure 11). By controlling which combinations of mutagenic megaprimers are made, 
potentially favorable combinations of mutations can be screened while limiting the overall size 





Figure 11. Boolean OR-type library design process.  (A→B) Asymmetric PCR is used to 
create mutagenic megaprimers, each containing one degenerate codon. (C→D) Mutagenic 
megaprimers are strategically combined to produce inserts that can be incorporated into a full 
library. Figure adapted from “Fast and Flexible Synthesis of Combinatorial Libraries for 
Directed Evolution”32. 
 
Similar to soft randomization, a Boolean OR-type library limits the number of mutations 
introduced to an individual SH2 mutant and decreases the likelihood of disrupting a mutant’s 
tertiary structure. By lowering the library size while maintaining a diverse set of mutations, it 
becomes easier to screen a wide array of potentially functional mutants than with a typical 
library containing a large number of mutated residues.  
In order to make this (or any) library creation technique effective, it is important to 
choose mutations carefully. Computational modeling is increasingly being used to determine 
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which residues would be useful to mutate, especially when crystal structures of a protein are not 
available33,34. When crystal structures are available, as was the case for SH2, these can also be 
used to guide the decision. 
Once a library is successfully produced, one must also consider which selection strategy 
is used to screen the library. Briefly, the two main considerations are the choice of helper phage 
to use (monovalent or oligovalent display) and the choice of peptide to select for or against 
(sulfotyrosine or phosphotyrosine). Other considerations include experimental conditions for 
phage elution and selection. These considerations were deemed unnecessary for this small library 
and are discussed more in-depth in the large library screening in Chapter 3. 
 
4.2 RESULTS AND DISCUSSION 
By examining an available crystal structure of SH2 bound to phosphotyrosine (PDB: 
1SPS), five residues in the binding pocket were chosen for hard randomization. Today, there are 
also methods for selecting mutation sites computationally33, which should be explored more 
heavily in the future. 
These residues were separated into three regions according to the protein’s primary 
sequence (Region 1: R15 & E19; Region 2: T40; Region 3: H61 & K63) and are shown in 
Figure 12. Residues were chosen due to their important structural roles, which could help 
optimize the SH2-3.1 binding pocket further. Notably, E19 has not been randomized in any 
previous work to modulate the SH2 binding pocket for higher affinity toward sulfotyrosine, but it 
was chosen based on its proximity to the binding pocket and its possible interaction with H61.  
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Figure 12. Residues chosen for hard randomization in Boolean OR-type library. Residues 
were chosen based on their proximity to each other in a crystal structure, and they were divided 
into three distinct regions based on distances between amino acids within the primary sequence 
(Region 1: R15 & E19; Region 2: T40; Region 3: H61 & K63). 
 
Once residues were chosen, the first step to creating a Boolean OR-type library was 
designing primers. The sequences are depicted in Table I, and parameters are discussed in 
Chapter 5. Once primers were designed, tests of asymmetric PCR for megaprimer assembly were 
conducted using symmetric PCR as a control. In the first trials, no asymmetric PCR product was 
observed (Figure 13A). Subsequent attempts optimized PCR conditions to obtain and eventually 
increase the yield of megaprimers (Figure 13B). In the optimized protocol, 5 more cycles were 
used (30x as opposed to 25x) and the ratio of forward primer to mutagenic primer was increased 
from 20:1 to 100:1. This was based on notes from a published protocol32. The optimized 
asymmetric PCR also showed a band of high electrophoretic mobility that likely corresponded to 
the excess primer. In Figure 13B, the higher yield of primer during symmetric PCR may have 
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been due to the higher concentration of both the forward and reverse primers in this reaction. 
However, this large difference in yield between symmetric and asymmetric PCR reactions did 
not occur in a published protocol32, which may suggest that further optimization of these 
methods is possible.  
  
Figure 13. Tests of mutagenic megaprimer formation. (A) The first test of mutagenic 
megaprimer formation. Lane 1 shows symmetric PCR product, but no DNA is observed in Lane 
2. (B) The optimized mutagenic megaprimer generation. Lanes 1 and 3 show symmetric PCR 
product, and Lanes 2 and 4 show faint bands containing sufficient amounts of asymmetric PCR 
product. Lane L contains a 1000kb ladder with banding at 50bp increments. 
 
The optimized PCR protocol was used to generate megaprimers with one degenerate 
codon for each of the desired residues to be mutated. Megaprimers were then combined together 
in PCR reactions, and CombiGenie (http://combi.synbiochem.co.uk) was used to calculate the 
amount of megaprimer to be used in each reaction. This was important because using equal 
amounts of megaprimers with different lengths was shown to bias libraries toward only 
incorporating mutations from the longer megaprimer32.  
Test reactions were conducted to produce full library inserts using one, two, and three 
megaprimers, and the products of these tests were sent for sequencing. Sequencing of the inserts 
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suggested that mutations were incorporated when one or two megaprimers were used, but not 
when three were used at once. Library construction therefore involved only two mutagenic 
megaprimers per reaction, for a total of eight possible combinations of degenerate codon pairs 
within different regions of the primary sequence (R15/T40, R15/H61, R15/K63, E19/T40, 
E19/H61, E19/K63, T40/H61, and T40/K63). 
When full inserts were generated using each combination of primers, gel electrophoresis 
of the PCR products revealed three distinct bands (Figure 14). This was also the case in the 
published protocol32, but no cause of the banding pattern was discussed. In any case, the 
expected length of the insert was 429 base pairs in length, which corresponded to the second 
band in each lane. This band was therefore extracted and used for Gibson assembly and 
transformation.  
 
Figure 14. PCR products of megaprimer combinations for Boolean OR-type library. Each 
numbered lane contained PCR products from a reaction combining two mutagenic megaprimers. 
Lanes 1 and 2 combined R15 and T40 megaprimers, which bled into two wells. Lane 3 combined 
R15 and H61 megaprimers. Lane 4 combined R15 and K63 megaprimers. Lane 5 combined E19 
and T40 megaprimers. Lane 6 combined E19 and H61 megaprimers. Lane 7 combined E19 and 
K63 megaprimers. Lane 8 combined T40 and H61 megaprimers. Lane 9 combined T40 and K63 
megaprimers. Lanes L contained a 1kb ladder. 
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The SH2-3.1 library DNA diversity was 1.31 x 105, so the desired transformation 
efficiency must be at least three times this amount35 (3.93 x 105) to cover the entire library. 
When chemical transformation was attempted, the transformation efficiency was too low (1.83 x 
104), so the insert was purified further to lower the salt concentration, and it was then used in 
another Gibson assembly followed by electroporation. This transformation was successful, with 
a transformation efficiency of approximately 8.63 x 105. Purified DNA from 24 colonies was 
sent to Eurofins MWG Operon for sequencing. To minimize the number of sequencing tubes 
required, each tube contained DNA from 4 colonies, and results from one sequencing tube are 
depicted in Figure 15. The combined results from every sequencing tube suggested the 
successful incorporation of mutations at all five residues.  
 
Figure 15. Sequencing results from Boolean OR-type library. (A) The sequence alignment 
with Boolean OR-type library template. Each mutated codon is highlighted in orange. 3.1 
mutations S37P, E38H, and T39F are also present. (B) A chromatogram showing the presence of 
mutations to R15. (C) A chromatogram showing the presence of mutations to T40. (D) A 
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chromatogram showing the presence of mutations at K63, even though this was not evident in 
the sequence alignment. 
 
Following validation of the library through sequencing data, a selection process was used 
to identify mutants with an increased affinity for sulfotyrosine over phosphotyrosine. The 
scheme involved three rounds of positive selection using the hyperphage system and an sYEEI 
peptide (Figure 16), the details of which are discussed in Chapter 3. The use of exclusively 
positive selections relied on knowledge from previous selection attempts on other SH2 libraries, 
which found that negative selections were ineffective for identifying sulfotyrosine specific 
mutants, possibly because they were too stringent.  
 
Figure 16. Selection strategy for Boolean OR-type library. Each component is 
described in more detail in Chapter 3. 
 
Unfortunately, the selection scheme never resulted in any observable enrichment above 
the control. This suggested that the library did not produce any beneficial mutants, which may be 
due to the library’s relatively small size compared to other attempted libraries in the Guo Lab.  
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When examining the results, it is interesting to note that no template SH2-3.1 hits were 
identified. This was unexpected, because previous work in the Guo Lab showed that this hit had 
improved selectivity for sulfotyrosine. Because it was used as the template strand for the 
Boolean OR-type library, the SH2-3.1 mutant was likely present within the library. This suggests 
that there may have been human error in the phage display experiments. Because it was one of 
my earliest attempts at phage display, this is entirely possible. Subsequent attempts to select from 
this library may be able to enrich, at the very least, the SH2-3.1 mutant. 
It is also possible that the selection was done correctly, and random chance in the first 
round of selection removed any SH2-3.1 mutants present in the portion of the library that was 
screened. If this is the case, there is no guarantee that other beneficial mutants were not also 
removed from the library. To correct this and determine the source of error, it may be helpful to 
conduct the same selection procedure using two starting cultures and two neutravidin wells. If 
both show similar results and no return of the SH2-3.1 mutant, this could suggest a bias in the 
library design, which did may not have captured all possible DNA sequences. If both show 
inconsistent results, this could suggest that the standard selection strategy is too stringent and 
should be modified to prevent the loss of beneficial mutants in the first round of panning. 
Modifications could include reducing the selection stringency with methods described in Chapter 
3, increasing the size of starting cultures and the number of neutravidin wells that are a part of 





There is much to be learned from an examination of new techniques for directed 
evolution. New strategies are continuing to be developed25, with computational methods playing 
an increasingly large role33. Based on this knowledge, computational methods should be 
explored further for the strategic design of future libraries. Though these experiments were 
unsuccessful at identifying any sulfotyrosine superbinders, they do show proof-of-concept for the 
design of a Boolean OR-type library, along with a reflection into some possible errors. If there 
are future promising SH2 mutants, this library design strategy may be useful for the 
identification of additional beneficial mutations using the promising SH2 mutant as a template. 
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CHAPTER 5: MATERIALS AND METHODS 
 
5.1 GENERAL MATERIALS AND METHODS 
Agar Plates, Liquid Media, and Antibiotics. All E. coli strains used in transformation and phage 
display were grown on agar plates containing appropriate antibiotics. Maintenance of the pSEX 
plasmid required 100ug/mL ampicillin. TOP10F’ E. coli required 5ug/mL tetracycline to 
maintain the F’ episome, and CJ236 E. coli required 50ug/mL kanamycin to maintain the F’ 
episome. 50mg/L kanamycin was also required to maintain the presence of M13KO7 and 
hyperphage replication phagemids. At certain steps in phage propagation and selection, 100mM 
glucose was used to prevent expression of the SH2 gene. SOC media was used for recovery 
following electroporation. 2xYT media [16g/L tryptone, 10g/L yeast extract, 5g/L NaCl] was 
used for phage propagation. 
 
PCR. A typical 25uL PCR reaction contained 2.5uL 2mM dNTP, 2.5uL 10x reaction buffer, 
1.5uL MgSO4, 10ng DNA template, 0.75uL 10uM primer mix, and 0.5uL KOD Hotstart 
polymerase, diluted with H2O until the total volume is 25uL. Thermocycler parameters are listed 
in Table II. 
 
Gibson Assembly. A solution containing equimolar concentrations of digested vector DNA and 
of each insert was added to a 2x Gibson assembly mix in a 1:1 volume ratio. The Gibson 




Chemical Transformation. Chemically competent TOP10F’ cells were produced using lab-
accessible standard operating protocols and were either used immediately or stored at -80 oC for 
later use. ~100ng of DNA was incubated with ~50uL of chemically competent TOP10F’ for 10 
minutes on ice. Cells were heat-shocked at 42oC for 35 seconds, then left on ice for 2 minutes. 
Next, 200uL of SOC media was added to recover the cells. Cells were incubated for 1hr in a 
37oC shaker [250rpm], and after incubation, dilutions were plated with appropriate antibiotics to 
assess the transformation efficiency. Cells that were not used in the dilution were added to a 
larger overnight culture with appropriate antibiotics and glucose. Plates and overnight culture 
were left in a 37oC incubator or 37oC shaker [250rpm], respectively. 
 
Electroporation. Electrocompetent TOP10F’ cells were produced using lab-accessible standard 
operating protocols and were either used immediately or stored at -80 oC for later use. DNA and 
electrocompetent cells were kept on ice prior to electroporation. A small amount of DNA was 
added to the electrocompetent cells, and the cell/DNA mixture was added to each pre-chilled 
2mm cuvette. Cuvettes were dried and electroporated at 2500V to allow for cellular uptake of 
DNA. Time constants of 5.6-6.0ms were considered successful. Immediately following 
electroporation, cells were recovered using pre-warmed SOC media. Cells were incubated for 
1hr at 37oC [250rpm]. After incubation, serial dilutions plated with appropriate antibiotics to 
assess transformation efficiency, and SOC media containing transformed cells was added to a 
larger overnight culture with appropriate antibiotics and glucose. Plates and overnight culture 
were left in a 37oC incubator and 250rpm shaker, respectively. 
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Sequencing. To sequence DNA, 200ng of DNA and 2uL of 10uM primer was used, diluted with 
H2O to a 10uL total volume. Primers were forward or reverse primers that overlapped a region 
outside of the SH2 coding region (Table I). Sequencing was carried out by Eurofins MWG 
Operon. 
 
5.2 CHAPTER 2 MATERIALS AND METHODS 
The materials and methods used in this chapter were adapted from “Creation of phosphotyrosine 
superbinders by directed evolution of an SH2 domain”26 and “Phagekines: Screening binding 
properties and biological activity of functional cytokines displayed on phages”29. 
 
Generation of template. Overlapping PCR was used to modify the pSEX-Src-SH2 wild-type 
plasmid to contain TAA stop codons at each of the residues to be mutated. This template was 
then chemically transformed into CJ237 cells infected with M13KO7. CJ237 was grown in 
media containing 100mg/L ampicillin and 50mg/L kanamycin to ensure maintenance of the 
pSEX plasmid and the F’ episome, respectively. dUssDNA was isolated using the Qiagen 
QIAprep Spin M13 Kit. Prior to Kunkel mutagenesis, products were analyzed in a 1% agarose 
gel to validate the presence of dUssDNA. 
 
Kunkel mutagenesis. Two published protocols with slight variations were attempted26,29. A 
complete list of primers and their sequences are depicted in Table I. Primers were 
phosphorylated with T4 polynucleotide kinase. T7 polymerase was used to elongate the primers. 
T4 ligase was used to ligate multiple segments of DNA together. Each Kunkel mutagenesis 
product was subject to DNA gel electrophoresis, and the band presumed to contain heteroduplex 
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CCC-dsDNA was extracted using a DNA gel recovery kit. Recovered DNA was transformed 
into TOP10F’ via electroporation. Purified plasmid DNA was sent to Eurofins MWG Operon for 
sequencing to assess library diversity using forward and reverse primers that annealed beyond 
the SH2 coding region (Table I).  
 
5.3 CHAPTER 3 MATERIALS AND METHODS 
Phage propagation. Each round of selection began with a 1-2% subculture of E. coli from the 
previous round of selection (or from the full library for the first round of selection). Each 
subculture was between 5 and 10mL and contained 2xYT media, ampicillin, tetracycline, and 
100mM glucose. The subculture was left in a shaker at 37oC and 250rpm until OD600=0.5 (~3-
4hr). At this point, hyperphage or M13KO7 was added to a multiplicity of infection (MOI) of 20. 
During phage infection, cells were incubated at 37oC for 30min, then were transferred to a 
250rpm shaker for another 30min. Cells were then pelleted at 3220xg for 10 minutes, 
resuspended in 8x the initial culture volume of 2xYT, ampicillin, and kanamycin, and left at 
250rpm and 37oC to grow overnight. The following morning, phages were precipitated by 
centrifuging 20mL of the overnight culture for 10min at 16,000xg. The supernatant was 
transferred to a new tube with 5mL of 5x PEG NaCl [20% PEG, 2.5M NaCl] to precipitate the 
phages, and the solution was left for 1hr on ice. Next, the phages were pelleted at 16,000xg for 
10 minutes, the supernatant was discarded, and the phages were pelleted at 5,000xg for 3 
minutes. Excess liquid was removed, and the pellet was resuspended in 200uL of phage blocking 
buffer [PBS pH 7.4, 0.05% Tween 20, 0.2% BSA] and transferred to a 1.5mL tube. This tube 
was then spun at 21,000xg for 5 minutes to remove debris while keeping phage within solution. 
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Next, the supernatant was transferred to a new tube and a Nanodrop 2000 was used to determine 
phage concentration (Concentration is 5x1012 pfu/mL when OD268=1).  
 
Selection. Neutravidin wells [Thermo Fischer Scientific] were washed 3x with 200uL of phage 
washing buffer [PBS pH 7.4, 0.05% Tween-20]. Each selection required 2 wells, one containing 
immobilized peptide [CHI Scientific], and one blank well as a control. To immobilize the 
peptide, 100uL of a 1ug/mL solution of the peptide, or 100uL of peptide dilution buffer [PBS pH 
7.4, 0.1% BSA, 0.1% NaN3] was added to appropriate wells. Wells were incubated for 1hr at 
room temperature. After immobilization, wells were washed 3x with 200uL phage washing 
buffer. Then, wells were incubated with 100uL of phage diluted with phage blocking buffer to 
cover 5,000x the library diversity for 1hr at room temperature. After incubation, wells were 
washed 10x with 200uL phage washing buffer. Next, 100uL trypsin [10ug/mL] was added to 
release immobilized phage, and the wells were incubated for 30min at 37oC. The solution within 
each well was added to 10mL of TOP10F’ and left for 30 minutes at 37oC stationary and 30 
minutes in a 250rpm shaker to allow for phage infection. After incubation, solutions were 
centrifuged at 3220xg for 10 minutes, and the supernatant was removed. Pelleted cells were 
resuspended in 1mL 2YT, dilutions were plated with ampicillin, tetracycline, and 100mM 
glucose to compare phage enrichment between blank wells and wells containing immobilized 
peptide. Non-blank cells that were not used in the dilutions were added to a 20mL culture with 
the same antibiotics and glucose concentration. This culture was allowed to grow overnight at 
37oC and 250rpm for use in subsequent phage propagation or glycerol stock preparation. 
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Enzyme Linked Immunosorbent Assay. Phage was precipitated following protocol listed in 5.3. 
To conduct the ELISA, 9 wells were required for each selection strategy to obtain triplicate 
measurements of blank wells, wells immobilized with a sulfopeptide, and wells immobilized 
with a phosphopeptide. 100uL of peptide dilution buffer or the appropriate peptide was incubated 
in each well for 1hr. After peptide immobilization, each well was washed 3x with 200uL of 
phage wash buffer. Next, 100uL of 1x1012 pfu/mL of phage precipitated from each selection was 
incubated for 1hr in each well. After incubation, each well was washed 5x with phage wash 
buffer. 100uL of 1:3000 dilution of anti-M13KO7 antibody was added to each well for 30min, 
and wells were then washed 5x with 200uL of phage wash buffer. Immediately following the 
wash step, 100uL of tetramethyl benzamidine was incubated for 15min. This step light-sensitive, 
so wells were covered with tin foil. After exactly 15 minutes, the reaction was quenched with 
50uL of H2SO4, and an H1 synergy plate reader was used to collect OD450 measurements from 
each well. These measurements corresponded to the amount of phage within each well. 
 
5.4 CHAPTER 4 MATERIALS AND METHODS 
A more detailed list of materials and methods used within this chapter can be found within the 
publication “Fast and Flexible Synthesis of Combinatorial Libraries for Directed Evolution”32. 
 
Initial primer design. Primers were designed with degenerate codons toward the center of the 
primer as much as possible. All primers were analyzed in Oligoanalyzer to ensure that all 
estimated melting temperatures (Tm) were between 77
oC and 79oC. Hairpins were kept below 
56oC, which was below the annealing temperature for most reactions. Primers were purchased 
from Sigma Aldrich. 
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Generation of megaprimers.  Asymmetric PCR was used to produce single-stranded 
megaprimers. A typical 25uL reaction included 2.5uL 2mM dNTP, 2.5uL 10x reaction buffer, 
1.5uL MgSO4, 0.25ng plasmid template DNA, 1.25uL 10uM SH2-Reverse primer, 0.6uL 1uM 
mutagenic primers, 0.5uL KOD Hotstart polymerase, and H2O added until the total reaction 
volume was 25uL. Symmetric PCR reactions, which were run as a control, contained 1.25uL of 
10uM SH2-reverse primer and 1.25uL of 10uM mutagenic primer, with all other parameters kept 
constant. Thermocycler settings are listed in Table III. 
 
Generation of full insert. PCR reactions containing the SH2-Forward primer and two mutagenic 
megaprimers were used to generate the full library. A typical 25uL reaction contained 2.5uL 
dNTP, 2.5uL 10x buffer, 1.5uL MgSO4, 0.5uL plasmid template (0.25ng), 1.25uL of 10uM 
SH2-Forward primer, a variable amount of each mutagenic megaprimer, 0.5uL KOD HotStart 
polymerase, and H2O added until the total reaction volume was 25uL. The concentration of each 
mutagenic megaprimer required for each reaction was dependent of megaprimer length and was 
calculated using CombiGenie (http://combi.synbiochem.co.uk). After sequencing confirmed the 
presence of mutations in each insert, Gibson assembly was used to ligate the full library together, 
and electroporation introduced the library into TOP10F’ E. coli. 
 







Table I. Comprehensive Primer List. N: Equal probability of A, C, G, or T. K: Equal 
probability of C or G. N1: 70% A, 10% C, 10% G, 10% T. N2: 10% A, 70% C, 10% G, 10% T. 
N3: 10% A, 10% C, 70% G, 10% T. N4: 10% A, 10% C, 10% G, 70% T. 
Primer Name Sequence 
SH2-Forward 5’ GCT GGC AGC TCA GCC GGC CAT GGC GGA CTA 
CAA AGA CGA CGA C 3’ 
SH2-Reverse 5’ CTT TCA ACA GTT TCA GCG GAT CCT CTG ATA TCT 
TTC TTG GAC GTG GGG CAC AC 3’ 
Sequencing-Forward 5’ GGC TCG TAT GTT GTG TGG 3’ 
Sequencing-Reverse 5’ CTA AAG TTT TGT CGT CTT TCC 3’ 
Primer 1-Kunkel 
Mutagenesis 
5’ TTT GGC AAG ATC ACC N1N3N1 N2N3N3 GAG 
N1N3N2 GAG CGG TTA CTG CTC 3’ 
Primer 2-Kunkel 
Mutagenesis 
5’ GG GAC CTT CTC GTG N2N3N1 GAA N1N3N2 N3N1N3 
N1N2N2 N1N2N3 AAA GGT N3N2N2 TAC N4N3N2 
N2N4N2 N1N3N2 GTG TCT GAC TTC GAC 3’ 
Primer 3-Kunkel 
Mutagenesis 
5’ AAG GGC CTC AAC GTG N1N1N3 N2N1N2 TAC 
N1N1N3 ATC CGC AAG CTG GAC 3’ 
Boolean-OR R15 5’ TAT TTT GGC AAG ATC ACC NNK CGG GAG TCA 
GAG CGG TTA CTG CTC AAT GCA 3’ 
Boolean-OR E19 5’ TAT TTT GGC AAG ATC ACC AGA CGG GAG TCA 
NNK CGG TTA CTG CTC AAT GCA 3’ 
Boolean-OR T40 5’ TTC CTC GTG CGT GAA CAT CCT TTT NNK AAA 
GGT GCC TAC GCC CTC TC 3’ 
Boolean-OR H61 5’ AAG GGC CTC AAC GTG AAG NNK TAC CTG ATC 
CGC AAG CTG GAC AGC 3’ 
Boolean-OR K63 5’ AAG GGC CTC AAC GTG AAG CAC TAC NNK ATC 
CGC AAG CTG GAC AGC 3’ 
 
 
Table II. General PCR parameters. 
Stage Temperature (oC) Time (Min:Sec) 






Final Extension 70 3:00 







Table III. PCR Parameters for creation of Boolean OR-type library megaprimers. 
Stage Temperature (oC) Time (Min:Sec) 






Final Extension 70 3:00 
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